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INTRODUCTION  
Spermicidal agents are defined as drugs that have the 
ability to immobilize or kill the sperm upon contact. An 
ideal spermicide should immediately and irreversibly 
produce immobilization of the sperm, nonirritating to the 
vaginal and penile mucosa, not have adverse effects on the 
developing fetus, free from long term topical and systemic 
toxicity and should not be systemically absorbed1,2. 
Spermicides as a contraceptive methods have advantages as 
that they do not depend on high skilled personnel for their 
prescription and use, they don’t interact systemically or 
interfere with absorption of other drugs, they are used on 
demand only not on exact time that may be not 
remembered also it isn’t hormones that may disturb woman 
body by effecting on ovulation, lactation or others3. 
Spermicides disadvantages appear as higher rate of failure 
than hormonal methods, vaginal irritation and vaginal 
secretions which appear mainly on frequent use4. N-9 
spermicides have a failure rate of 18% per year on perfect 
use, and 29% under typical use5 and irritation rate was 
recorded 12% of participants sharing in clinical trial at 
20006. on comparing advantages to disadvantages we found 
spermicide can be better contraceptive method than other 
hormonal method on treating their problems. N-9 which is 
the most popular spermicide had low acceptability (16.9%) 
and it offered to women looking for a short term, user-
controlled contraceptive7.  
 Zinc acetate is another approved spermicide which has a 
spermicidal effectiveness in a 1% concentration it appears 
this is due to the acetate in zinc acetate which can decrease 
oxygen utilization by sperm8. Zinc acetate came over N-9 
as it doesn’t cause irritation but it can reduce irritation of 
the mucosal tissue if found due to zinc ion that is effective 
in preventing or reducing irritation in a concentration of 
0.5% which avoid zinc toxicity9. Effective concentrations 
of Nonoxynol-9, benzalkonium chloride, zinc acetate, 
cupric chloride, cysteamine, tannic acid and propranolol 
ranged at least from 0.15 to 1% 10. N-9 spermicidal activity 
can withstand to 6 hours11. While, zinc acetate spermicidal 
activity can withstand for only one hour12. Addition of Zn 
(OAC)2 to N-9 was a trial to produce a new product has 
advantages of both spermicides together. 
In this study we suggest that the prepared spermicide 
vaginal suppository contain N-9 and Zn (OAC)2 in 
concentration 10:1 respectively possess more advantages 
over presently marketed formulations which contains N-9 
alone for the causes that mentioned before. New 
preparation contains N-9 plus Zn (OAC)2 salt was tested in-
vivo and in-vitro in compare with market suppositories 
containing N-9 alone.  
MATERIALS AND METHOD 
1. Materials 
1. Nonoxynol-9 was purchased from Sigma Aldrich 
chemical Co. St Louis, Mo, (USA), 2. Zn acetate di-
hydrate, Sodium lauryl sulfate, Sodium bicarbonate and 
Anhydrous Citric acid were purchased from El-Gomhouria 
Pharmaceutical Chemical Co. (Egypt). 3. Polyethylene 
glycol base (6000, 400) were purchased from EI-Nasr 
Pharmaceutical Chemical Co. (Egypt) and 4. No Gravida® 
suppository was purchased from DKT (Egypt). 
Semen samples 
Fresh human semen Samples having >65 x 106/ml sperm 
count with >70% motility and normal sperm morphology. 
Samples obtained by masturbation into a sterile vial from 
healthy, young, and fertile donors.  Normal ejaculate 
volume is between 2 and 6 ml, pH is 7.2-8.0 and color is 
gray yellow.  
2. Equipment 
1. Electronic balance, Metler Co, (Swizerland). 2. Stainless 
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steel suppository molds (2.5 cm in heights and 1.5 cm in 
thickness) self-made. 3. USP tablet dissolution test 
apparatus ӀӀ, Hanson research, California, (USA). 4. 
UV\VIS double beam Spectrophotometer, spectronic, 
Genesys, Milton Roy Co., (USA). 5. Light microscope, 
XSP- 13A, Chene MA, (China).  
3. Methods 
3.1. Suppository formulation 
Suppository formulations were prepared from water soluble 
bases (PEG 400 and PEG 6000) by melting method13. The 
molten base was poured into a mold of torpedo shape then 
refrigerated and packaged. Each 2 gm. vaginal suppository 
contains 100 mg N-9 and 10 mg Zn (OAC)2. 
3.2. Drug release measurement of the prepared 
suppository 
Dissolution was conducted in the USP dissolution 
apparatus 2 operating at 50 rpm using 500 ml of distilled 
water at 37ºC. 5 ml samples were taken at different time 
intervals and replaced with 5 ml of fresh dissolution 
medium maintained at the same temperature. Samples were 
taken with filter-tipped pipette and analyzed 
spectrophotometrically at 276 nm for N-9 13, while zinc 
acetate was analyzed at 550 nm14.  Results were plotted 
against time in the representative curve. Release of N-9 
from the combination in the prepared suppository was 
compared with N-9 release lonely as reported by Parrott 12 
and determined at the same time intervals so we can study 
changes made on addition of zinc acetate. 
3.3. In-vitro study                                                                               
Human males participating in this study were fertile semen 
donors selected after appropriate screening. Three 
specimens from each of three males were used in this 
study. Specimens were collected by masturbation following 
three days abstinence. Following collection, specimens 
were incubated at 37ºC for 15-30 minutes to allow for 
liquefaction. Semen volume, sperm aggregation and 
motility percentage were assessed using a light microscope. 
Sperm motility and aggregation recorded as percent and 
best spermicide produce 100% sperm immobility and 100% 
aggregation. Motility was calculated according to the 
formula:                                                                                  
Motility = Motile sperms ∕ Motile + non motile sperms × 
100 
Sperm motility and sperm aggregation were measured 
before and after addition of spermicide on the semen 
samples after liquefaction and after one hour from 
liquefaction for testing different spermicides concentrations 
on it. Three dilutions were prepared from each suppository 
(with and without zinc acetate) A, B and C as seen in table 
1 from each type of suppository and they tested on semen 
samples for comparing market (No Gravida®) and 
prepared suppository in different concentrations. 
 
Table 1: Different dilutions of two spermicides formulas of in-vitro testing 
 
 
Formula 
 
 
 
% 
Spermicidal amounts (mg) 
Market suppository Prepared suppository 
N-9 N-9 Zn(OAC)2 
 
A 
 
2 
 
20 
 
20 
 
2 
 
B 
 
1 
 
10 
 
10 
 
1 
 
C 
 
0.5 
 
5 
 
5 
 
0.5 
 
250 µl from each dilution (solution A, B and C) of N-9 
alone suppository (market suppository) were added into 50 
µl of semen sample. Then start to vortex it at very low 
speed for 10 seconds. Drop of the mix is immediately 
examined under microscope. Result scored positive if 
100% of sperm are completely immotile within 20 seconds 
after dilution15.  Repeat the same procedure for the 
prepared suppositories contain N-9 and Zn (OAC)2 and 
determine the difference in results at different 
concentrations.  
3.4. In-vivo study 
The study recruited 78 participants referred for using 
spermicide suppository formulated of N-9  in PEG base 
(market or compounded) for conception purpose at family 
planning unite at General Abo-Korkase hospital and 
General Minia Hospital during the period from July 2010 to 
August 2011. Study was made to achieve two purposes 
from using the new spermicide which were decrease failure 
and irritation rates. This study is randomized prospective 
clinical trial. Randomization was computerized and blind.                                                                                                                                                                    
 We choose participants which have special criteria and 
accept the experiment and study17, 18. Participants should 
know as much as possible about the clinical trial.  
Participants in this study were informed and randomized to 
receive either N-9 suppository preparation or N-9 plus zinc 
acetate preparation as computer divides them. All 
participants would be instructed on the use of the test 
products18. Method of application is the most important 
point in clinical work-up as can change results at all; 
explain method for each volunteer. Verbal and written 
informed consent was obtained from all volunteers after 
giving information about the aim of the study and the 
procedure involved in it18.                                                                                         
 Participants would be followed through 12 menstrual 
cycles (approximately 13 months) at least and would have 
8 study visits and two studies phone call.   
All volunteers had comprehensive evaluation full history of 
taking other contraceptive methods and after using 
spermicides (market or prepared).  Special notes were made 
of the age, cycle length, literati, parity, previous method of 
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contraception and lactation. Notes were taken about 
pregnancy if occur, vaginal irritation, coital problems, 
cycle irregularities, secretions and other compliances after 
use19.                                                       
RESULTS AND DISCUSSIN 
Prepared suppository with zinc acetate mainly appeared to 
have similar physical quality properties to the market 
suppository as weight variations, melting point, hardness 
and others.  
The dissolution studying of the prepared suppository with 
zinc acetate has high dissolution rate and high drug release 
profile as it start release with high concentration that reach 
>95%  at first 18 min. 
The concentrations of N-9 was measured 
spectrophotometrically at 276 nm and it was increasing 
manner until it started to make plateau level after 20 min. 
that was compared to that made for N-9 by Parrott 13. Zinc 
acetate was measured spectrophotometrically at 550 nm 
and it was increasing manner at first 20 min and reaches to 
≥95%.  
Table (2) and figure (1) illustrate the high dissolution rates 
of both N-9 and zinc acetate in the prepared suppository. 
Release start from first 3 min in increasing manner and the 
maximum amount released were at 18 min. 
 
Table 2: Amount released of N-9 and Zinc acetate salt from the prepared suppository (at first 18 Min). 
Time  
(min) 
Amount  Dissolved of Zn(OAC)2 
(mg) 
Amount  Dissolved of N-9 (mg) 
0 0 0 
3 2.5 28.0 
6 5.7 38.0 
9 6.8 63.0 
12 8.2 80.0 
15 9.5 90.5 
18 9.5 98.7 
 
                                     
 
Figure 1: The dissolution rate of N-9 and Zn (OAC)2 
from the prepared suppository 
Table (3) and figure (2) show no significant difference in 
release of N-9 from market suppository as made by 
Parrote13 and that of prepared suppository and so Zn 
(OAC)2 don’t change N-9 release profile. 
Table 3: the amount released of N-9 from market 
suppository and the prepared suppository at first 18 
Min. 
Time  
(min) 
Amount  released of N-9 (mg) from 
Market suppository The prepared suppository 
0 0 0 
3 28.0 28.0 
6 36.0 38.0 
9 64.8 63.0 
12 81.2 80.0 
15 93.5 92.5 
18 97.8 98.7 
 
 
Figure 2: The release of N-9 from market suppository 
and from prepared suppository   
High dissolution rate return to the formula which contains 
N-9 as it is Non-ionic surfactant20 in non-ionic polymer of 
PEGs base. Zn (OAC)2 do not interact with it or impair N-9 
activity as the low concentration of Zn (OAC)2 salt (in 
compare to N-9 concentration)  prevents it from 
interference with N-9 add to that both active ingredients N-
9 and Zn (OAC)2 are highly stable components and need 
high temperature degrees to melt or interact.  
The in-vitro test made on human semen samples (out 
human body) for testing changes on sperm motility and 
sperm aggregation on addition of different concentration of 
two group of spermicides (with and without Zn (OAC)2) on 
it. 
Prepared suppository (N-9 plus Zn (OAC)2 ) show 
significant increase in efficacy of the formula in reduction 
of sperm motility and increasing sperm aggregation than 
market one in all dilutions especially before first hour 
passing. As illustrated in table (4). 
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Table 4: In vitro testing of motility and the aggregation of sperm after mixing with N-9 either alone or with zinc 
acetate suppository 
aggregation Sperm motility components 
concentrations After 
one hour 
After liquefaction 
p % p % P % Dil.  
_ 100  0  0     _     N-9 
100 0 0 N-9& Zn(OAC)2 
0.5 
 
75 0.1 
 
10 0.02* 20  
A 
N-9 
100 0 0 N-9& Zn(OAC)2 
0.5 75 0.13 20 0.16 40  
B 
N-9 
75 15 20 N-9& Zn(OAC)2 
0.3 50 0.16 30 0.03* 50  
C 
 
N-9 
75 20 20 N-9& Zn(OAC)2 
 
In-vitro test prove the role of zinc acetate addition to N-9 
that can increase spermicidal efficacy of the N-9 not 
diminish it. These results come right with16 and against9. 
Different mechanisms of two spermicides (N-9 and Zn 
(OAC)2 ) give the new formula of the combination high 
strength in reduction of sperm motility. Zinc acetate 
contains acetate ion which decreases oxygen utilization by 
sperm that the cause in decrease motility and increase in 
aggregation.8. Nonoxynol-9 vaginal spermicides interact 
with the lipoproteins of the cell membrane to permanently 
disrupt the cell membranes of spermatozoa, resulting in 
severe damage to the acrosome (head), neck, midpiece, and 
tail of the sperm and rapid, irreversible loss of function and 
motility within the vagina and viability11. Different 
mechanisms give the synergistic effect. 
In the clinical studying, When discuss the results related to 
reduction of irritations we found that after application of 
drug on group Ӏ (market supp.) and group ӀӀ (prepared 
supp.) as seen in table (5)  
 
Table 5: Rate of vaginal irritation in both groups of participants of clinical trial 
Vaginal 
Irritation 
Group Ӏ 
No. (%) 
Group ӀӀ 
No. (%) 
Total 
No. (%) 
p-value 
 
Yes 
 
8 (22.8) 
 
1 (8.1) 
 
9 (12.5) 
 
0.02* 
 
No 
 
27  (77.2) 
 
36 (97.9) 
 
63 (87.5) 
 
Total 
 
35 (100) 
 
37 (100) 
 
72 (100) 
 
 
The results were observed in the positive side as vaginal 
irritation decrease with a high significant difference 
(P=0.02) when zinc acetate salt added to N-9. Irritation in 
this context may be evidenced by redness or other changes 
in coloration, inflammation or swelling, hypersensitivity, 
the occurrence of burning, itching or other painful stimuli. 
So, zinc ion that is effective in preventing or reducing 
irritation in a concentration of 0.5% which avoid zinc 
toxicity9.  
The most common satisfied mechanism of zinc salt use as 
anti-irritant product was that zinc salts may prevent 
irritation by zinc ions which can bind to negatively-charged 
regions exposed on the surface of proteins and alter the 
charge configuration of the protein and prevent subsequent 
protein-protein interactions between irritants and exposed 
mucous membranes., thereby preventing its subsequent 
binding to the underlying tissue and so prevent irritation16.                                              
Failure which means pregnancy occur show the following 
results in the table (6).  
 
Table 6: Failure rate in both groups of participants of clinical trial 
Failure Group Ӏ 
No. (%) 
Group ӀӀ 
No. (%) 
Total 
No. (%) 
p-value 
 
Yes 
 
4 (11.4) 
 
0 (0) 
 
4 (5.5) 
 
0.03* 
 
No 
 
31 (88.7) 
 
37 (100) 
 
68 (94.5) 
 
Total 
 
35 (100) 
 
37 (100) 
 
72 (100) 
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The results show increase in the spermicidal efficacy of N-
9, Zn acetate combination than N-9 alone so that Zn acetate 
spermicidal effect can increase the efficacy of N-9 not 
reduce it. Failure rate of N-9 also decreased significantly (P 
value equal 0.03). Zinc acetate (and zinc gluconate on 
adjusting pH to 7.0) was proven as strong spermicide 
between zinc salts and useful as a vaginal contraceptive
8
. 
And we assure on Combining two birth control methods, 
can increase their effectiveness to 95% or more for less 
effective methods21.   
CONCLUSION 
Nonoxynol-9 is the active ingredient in all of the over-the-
counter (OTC) spermicidal products available in the 
markets and has been used for pregnancy prevention since 
the 1950s. but it start to be withdrawn from markets after 
compliance from it's high failure rate and low safety due to 
high irritation which lead to wounds and lesions that 
increase rate of sexual transmitted diseases. After screening 
in family planning clinics we found that local methods of 
contraception have high acceptability and high fair in the 
same time so, we tried to introduce a new formula which 
safe and effective. The new formula contains 0.5% 
concentration zinc acetate and 5% N-9 concentration which 
could produce a new spermicidal product with the best 
quality to the market as two components are approved 
spermicides at the mentioned concentrations. Different zinc 
salts as zinc lactate, zinc gluconate, zinc acetate, and other 
water-soluble organic zinc salts can reduce irritation caused 
by surfactants (nonoxynol or octoxynol) and other 
microbicides in topical genital formulations with different 
degrees but zinc acetate is the only spermicidal without any 
changes in its structure. Zinc-containing additives 
additionally can stabilize and protect cellular membranes, 
thereby helping protect genital surfaces against damage 
caused by repeated exposure to agents that attack the lipid 
membranes that surround mammalian cells. Suitable zinc 
Salts which have been tested and shown to be non-irritating 
during sexual intercourse include zinc acetate, zinc 
propionate, and zinc gluconate. Other zinc salts have also 
been identified which are soluble in water and have low pK 
values, which indicates a high rate of zinc ion release22. 
Our results reached to that addition of Zn (OAC)2 to N-9 
produced an effective spermicide product plus the 
demulcent effect of zinc ion which appears well at 0.5% 
concentration that came with16,12.   
So we recommended addition of zinc acetate salt to N-9 
spermicidal formula to reach the best properties of 
spermicidal contraceptive.                                                                                         
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